IMVT logo

Immunovant (IMVT) Company Overview

Profile

Full Name:

Immunovant, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

June 21, 2019

Indexes:

Not included

Description:

Immunovant (IMVT) is a biotechnology company focused on developing innovative therapies for autoimmune diseases. They aim to improve patients' lives by creating treatments that target specific immune system issues, particularly using monoclonal antibodies. Their lead product is designed to treat conditions like myasthenia gravis.

Events Calendar

Earnings

Next earnings date:

May 29, 2025

Recent quarterly earnings:

Feb 6, 2025

Recent annual earnings:

May 29, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 10, 25 HC Wainwright & Co.
Buy
Feb 10, 25 Guggenheim
Buy
Feb 7, 25 HC Wainwright & Co.
Buy
Jan 15, 25 B of A Securities
Buy
Jan 3, 25 Wolfe Research
Peer Perform
Dec 19, 24 Wells Fargo
Overweight
Nov 8, 24 HC Wainwright & Co.
Buy
Oct 9, 24 Oppenheimer
Outperform
Sep 30, 24 HC Wainwright & Co.
Buy
Sep 10, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Immunovant?
  • Does Immunovant pay dividends?
  • What sector is Immunovant in?
  • What industry is Immunovant in?
  • What country is Immunovant based in?
  • When did Immunovant go public?
  • Is Immunovant in the S&P 500?
  • Is Immunovant in the NASDAQ 100?
  • Is Immunovant in the Dow Jones?
  • When was Immunovant's last earnings report?
  • When does Immunovant report earnings?
  • Should I buy Immunovant stock now?

What is the ticker symbol for Immunovant?

The ticker symbol for Immunovant is NASDAQ:IMVT

Does Immunovant pay dividends?

No, Immunovant does not pay dividends

What sector is Immunovant in?

Immunovant is in the Healthcare sector

What industry is Immunovant in?

Immunovant is in the Biotechnology industry

What country is Immunovant based in?

Immunovant is headquartered in United States

When did Immunovant go public?

Immunovant's initial public offering (IPO) was on June 21, 2019

Is Immunovant in the S&P 500?

No, Immunovant is not included in the S&P 500 index

Is Immunovant in the NASDAQ 100?

No, Immunovant is not included in the NASDAQ 100 index

Is Immunovant in the Dow Jones?

No, Immunovant is not included in the Dow Jones index

When was Immunovant's last earnings report?

Immunovant's most recent earnings report was on Feb 6, 2025

When does Immunovant report earnings?

The next expected earnings date for Immunovant is May 29, 2025

Should I buy Immunovant stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions